Absence of Anti-Babesia microti antibody in commercial intravenous immunoglobulin (IVIG)

• Published in: PLoS neglected tropical diseases Vol. 18; no. 3; p. e0012035
• Main Authors: Kostka, Julia, Maharjan, Anu S., Kumar, Sanjai, Hackenyos, Douglas, Krause, Peter J., Dieckhaus, Kevin
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 01.03.2024; Public Library of Science (PLoS)
• Subjects: Antibodies; Antibody response; Antigens; Asymptomatic infection; B cells; Babesia microti; Babesiosis; Biology and Life Sciences; Care and treatment; Diagnosis; ELISA; Enzyme-linked immunosorbent assay; Enzymes; Flow cytometry; Health aspects; Health services; Human subjects; Immunocompromised hosts; Immunofluorescence; Immunoglobulins; Infection; Infections; Intravenous administration; Lymphoma; Medicine and Health Sciences; Monoclonal antibodies; Patient outcomes; Patients; Protozoa; Protozoal infections; Research and Analysis Methods; United States; United States > US

Babesiosis is a worldwide emerging protozoan infection that is associated with a spectrum of disease severity from asymptomatic infection to severe organ damage and death. While effective treatment strategies are available, some immunocompromised patients experience severe acute and prolonged/relaps...